Cite
HARVARD Citation
Powles, T. et al. (2023). Clarification needed for pembrolizumab as adjuvant therapy in clear cell renal cell carcinoma – Authors' reply. Lancet oncology. 24 (1), pp. e1-e2. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Powles, T. et al. (2023). Clarification needed for pembrolizumab as adjuvant therapy in clear cell renal cell carcinoma – Authors' reply. Lancet oncology. 24 (1), pp. e1-e2. [Online].